bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis

Area of Science:

• Oncology
• Molecular Biology
• Cell Death Research

Background:

• Apoptosis, or programmed cell death, is crucial for eliminating DNA-damaged cells.
• The bcl-2 proto-oncogene inhibits apoptosis, potentially leading to the accumulation of cells with genetic alterations.
• Colorectal tumorigenesis involves genetic changes that can disrupt normal cell death pathways.

Purpose of the Study:

• To investigate the activation of the bcl-2 gene during colorectal tumorigenesis.
• To determine the relationship between bcl-2 expression and p53 in colorectal cancer development.
• To assess the impact of bcl-2 on apoptosis rates in colorectal carcinomas.

Main Methods:

• Immunohistochemistry was used to analyze bcl-2 and p53 expression.
• Expression patterns were examined in normal mucosa, hyperplastic polyps, dysplastic polyps, and carcinomas.
• Histological assessment of spontaneous apoptosis rates was performed.

Main Results:

• bcl-2 expression shifted from basal cells in normal tissue to broader regions in dysplastic polyps and carcinomas.
• An inverse correlation between bcl-2 and p53 expression was observed in adenomas.
• Colorectal carcinomas with high bcl-2 expression exhibited significantly lower rates of spontaneous apoptosis.

Conclusions:

• Abnormal activation of the bcl-2 gene is an early event in colorectal tumorigenesis.
• bcl-2 activation inhibits apoptosis in vivo, potentially facilitating tumor progression.
• bcl-2 and p53 may regulate a common pathway involved in colorectal cancer development.